Moonwalk Biosciences Launches with $57 Million in Financing to Advance a New Class of Precision Epigenetic Medicines
January 04, 2024 08:00 AM Eastern Standard Time SOUTH SAN FRANCISCO, Calif. & SAN DIEGO–(BUSINESS WIRE)–Moonwalk Biosciences, a genomic medicine company pioneering precision epigenetic medicines, today announced the completion of $57 million in seed and…